As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content ...

Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...

A long-acting medicine developed by Novo Nordisk has been recommended as a treatment option for young people with growth ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

At ASCO 2025, Servier presented data in the IDH-mutated cancer space.

It is the first fundraising effort at Neuralink since its $280 million Series D round in 2023 and brings the company's total ...

The 5th iPSC Drug Development Summit serves as a pivotal platform for uniting iPSC-based drug developers across the value ...

Europe follows a similar pattern, with data from the EU Clinical Trials Information System (CTIS) estimating that less than 0 ...

Citylabs 4.0, now open in the heart of Manchester’s Knowledge Quarter on the Oxford Road Corridor, was built with exactly ...

At ASCO 2025, pharmaphorum web editor Nicole Raleigh sat down to discuss key highlights from the Congress with EVERSANA experts.

The new version of Sarclisa stems from a collaboration with Enable Injections, backed financially to the tune of €300 million ...

Multiple myeloma (MM) is an incurable haematological malignancy, but patient survival outcomes have been lately improved by ...